Pharmaceutical Sciences

Research

The department maintains a highly visible research program which focuses on the investigation of the pathophysiological mechanisms of chronic illness, development of innovative therapeutic and preventive strategies, as well as drug discovery and formulation of novel drug delivery systems. Students enrolled in the professional programs may participate in research under the mentorship of department faculty.

Cancer

The core group investigates cell signaling mechanism, genetic and epigenetic changes, along with treatment approaches such as chemoprevention and gene therapy.

For detailed information see the following faculty lab pages:

Metabolic & Liver Disease

Laboratory research focuses on various downstream targets and signaling in a variety of metabolic and liver disorders. Dr. You’s research focuses on elucidating downstream effects of alcohol administration. Dr. Sadana’s research focuses on molecular mechanism of hormone regulated gene expression in context of metabolic and cardiovascular disorders as well as targeting nuclear receptor mediated transcription.

For detailed information see the following faculty labs:

Neurodegenerative Diseases & Psychiatric Illness

The primary focus is elicitation of the pathophysiological and neurochemical mechanisms in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, stroke and glaucoma. Psychiatric illnesses such as autism, schizophrenia, PTSD and substance abuse. The group also focuses on development of novel therapeutic strategies and drug discovery.

For detailed information see the following faculty labs:

Drug Delivery Systems

The key focus of the group is on pharmaceutical engineering and development of novel delivery systems of therapeutic agents for the purpose of imaging, prevention and treatment of various diseases. The delivery systems include but are not limited to nanoparticles, liposomes, microemulsions and hydrogels. The main research targets are cancers (such as brain, breast and lung cancers), neurodegenerative and ocular disorders. Additional efforts are geared toward formulation and analytical development for pharmaceutical industries.

For detailed information see the following faculty labs:

Contact

Cheri Harris
Business Manager
Phone: 330.325.6689
Email: charris1@neomed.edu

Department Chair

Moses Oyewumi, Ph.D.
Phone: 330.325.6669
Email: moyewumi@neomed.edu

Department of Pharmaceutical Sciences

College of Pharmacy at NEOMED